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mean range shifts were measured to be smaller than the 
applied margins [Xie et al, IJROBP 99:210-218 2017]. In 
this study, we present the PG imaging results of a patient 
treated at the base of skull within a heterogeneous 
region. We evaluated the impact of changes in sinus 
filling on individual proton spot range retrieval to access 
the efficacy of the PG camera in detecting the 
anatomical change. Additional data analysis was 
conducted to evaluate strategies on how to visualize and 
interpret PG based range measurement data. 
Material and Methods  
The patient was treated for a malignant neoplasm of the 
brain near the base of skull receiving 54 Gy in 30 
fractions. During the course of treatment, an evaluation 
CT scan identified anatomical change in the nasal cavity 
(Figs. 1a and 1b) and the treatment plan was revised 
accordingly. Both the initial and revised plans consisted 
of three equally weighted fields. PG imaging data was 
recorded for eight fractions, including six with the initial 
plan and two with the revised plan. The knife-edge slit 
camera records the PG emission profile along the beam 
direction. The measured PG profiles were analyzed on a 
spot-by-spot level and compared to simulations. 
Results  
Based on PG emission simulations, two fields should 
exhibit over-ranges due to anatomical change. The PG 
based range measurements revealed over-ranges of up to 
4 mm in individual spots passing through the nasal cavity 
(Fig 1c), which agreed with the simulations from patient 
CT and initial treatment plans. Meanwhile, no over-
ranging was observed for the field that was not impacted 
by the anatomical change. For the revised plan, smaller 
range shifts were identified (Fig 1d). The data is 
presented in 3D to better visualize and identify the range 
deviations.  
Conclusion  
In this study, we presented patient PG measurements for 
a highly heterogeneous target volume, and identified 
over-ranges in the treatment volume corresponding to 
the anatomical change identified during an evaluation CT 
during the course of treatment. Smaller range deviations 
were observed using the revised plan. By using a 3D 
image of the range deviation map, we improved the 
visualization of PG data to identify range deviations 
relative to regions of anatomical change. PG imaging is a 
feasible tool to identify range deviations for 
heterogeneous targets. 
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Purpose or Objective  
The induced activity in linear accelerator components 
and treatment rooms is of importance when considering 
safety aspects concerning engineers and physicists 
performing measurements and maintenance at the 
accelerators. The literature is lacking studies on the 
effects of FFF (Flattening Filter Free) radiation and MLC 
(Multi-Leaf Collimator) parking, which we present in this 
work. 
Material and Methods  
Induced activity was measured using a pair of LUDLUM 
dosimeters (model 9DP with data logging), positioned as 
shown in Figure 1, at two Elekta linear accelerators with 
MLC160 (Agility) and MLCi2. The dosimeters were set to 
log data every five seconds. Following the day's 
treatments, 5000 MU (monitor units) were given with a 
10x10 cm2 field size. The dosimeters were outside the 
treatment room during the 5000 MU radiation and were 
placed as Figure 1 shows immediately after the 5000 MU 
had been given. One of the dosimeters was positioned as 
close as possible to the exit window, with the centre of 
the detector approximately 50 cm from the accelerator's 
X-ray target. The other dosimeter was placed outside the 
X-ray target at approximately 44 cm laterally from the 
target and 100 cm below the isocentre. The gantry angle 
was 180º during all measurements. Energies of 6 and 18 
MV were applied, in addition to 6 MV FFF at the MLC160. 
Measurements were also made with the MLCs in parked 
position.  
 
 
Figure 1: The measurement set-up. 
Results  
Figure 2 shows the results of the measurements. For 18 
MV at the MLCi2 (Figure 2a)), higher dose rates are 
measured at the exit window initially, compared to 
target level, until after about 45 minutes, when the dose 
rates are the same. The target level dose rate is slightly 
higher than at the exit window thereafter. Figure 2b) 
shows the sudden drop in dose rate when parking the 
MLCs after 5000 MU at 18 MV at the MLCi2. Figure 2c) 
shows the results at the exit window of the MLC160, 
where the MLC was parked twice at 6 MV FFF. Figure 2d) 
shows the target level results for the MLC160 . 
 
 
Figure 2: a) 18 MV, MLCi2. b) 18 MV including 
measurements during the MCLi2 parking after 16-17 
minutes. c) Comparison of 18 MV, 6 MV, and 6 MV FFF, 
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exit window, MLC160. The MLC160 was parked twice 
during the 6MV FFF measurements. d) target level at the 
MLC160 for 18 MV, 6 MV, and 6 MV FFF. 
The maximum induced dose rate was 23 µSv/h for 18 MV 
at the exit window. The dose rate with the MLCs in the 
parked position is approximately 3 µSv/h after applying 
5000 MU at 18 MV. For lower photon energies, the 
maximal dose rate was 1 µSv/h for 6 MV FFF. 
Conclusion  
We confirm that induced activity primarily occurs at 
photon energies above 10 MV (Perrin et al, Phys. Med. 
Biol. 48, N75-N81, 2003), as we measure the greatest 
activity at 18 MV. After 45 to 60 minutes the induced 
activity is greatest at the target level. The dose rate for 
the MLCs in the parked position is more than 7 times 
lower than for a 10x10 cm2 field. Higher dose rates are 
measured with FFF, suggesting a filter shielding effect. 
 
EP-1803  Dosimetric and radiobiological validation of 
Acuros XB algorithm in thoracic radiation therapy 
C. Khamphan1, A. Delbaere1, A. Chaikh2, J. Balosso3, R. 
Garcia1 
1Institut Sainte Catherine, Medical Physics Department, 
Avignon, France 
2CHU, Radiotherapy, Grenoble, France 
3Université Grenoble Alpes, Rayonnement synchrotron et 
recherche médicale, Grenoble, France 
 
Purpose or Objective  
Acuros-XB (AXB) algorithm has been introduced several 
years ago in order to improve the accuracy of dose 
calculation in radiotherapy, especially in the presence of 
tissue heterogeneities. This type (c) algorithm is based on 
the deterministic resolution of the linear Boltzmann 
transport equation and offers results close to Monte Carlo 
simulations. 
This study aims to evaluate the clinical impact of a new 
algorithm by comparing the dosimetric and 
radiobiological results of the AXB algorithm for its two 
reporting modes (dose to water AXB-Dw and dose to 
medium AXB-Dm), compared to a reference algorithm: 
the Anisotropic Analytical Algorithm (AAA).Material and 
Methods  
Ten cases of patients treated for lung cancer with 
conformational radiotherapy were studied. For each 
patient, five treatment plans were generated. The dose 
in plans 1, 2 and 3 was respectively calculated with AAA, 
AXB(Dm) and AXB(Dw), using the same prescribed dose 
(PD). In plans 4 and 5, the dose was calculated using the 
two AXB calculation modes with the same number of 
monitor units (MU) derived from the AAA calculation 
(plan 1). The dosimetric evaluation was based on the 
comparison of dose volume histograms (HDV) and quality 
metrics (i.e. Conformity, Coverage and Homogeneity 
indices). Radiobiological assessment was based on the 
comparison of tumor control probabilities (TCP) and 
toxicity probabilities (NTCP) for organs at risk (OARs), 
including lungs, esophagus and heart. Wilcoxon and 
Spearman’s rank tests were used to calculate p-values 
and the correlation coefficient (ρ). 
Results  
Using the same PD, we observed a significant increase in 
the number of MU (1%-4%), depending on the choice of 
AXB-Dm or AXB-Dw. In dosimetric terms, dose calculated 
with AXB is more heterogeneous. This introduces a 
significant decrease in the minimum dose to the PTV and 
in the quality indices. These elements can influence the 
therapeutic results. In addition, the dose to OARs was 
increased from +2% to + 10%. The increase in dose to 
target volumes and OARs with AXB, using the same PD, 
explains the increase in TCP (+1% to 2%) and in NTCP 
(+2%) (p <0.01). 
 
 
Conclusion  
AXB algorithm is known to provide improved calculation 
accuracy. However, a special attention is required in 
order to safely implement its clinical use. Depending on 
the medium density, the technique and the treatment 
field size, MU can increase as well as the dosimetric 
values and the NTCPs. Radiation oncologists and medical 
physicists should define together the attitude to be 
adopted regarding these dosimetric shifts. A reasonable 
approach would be to keep the same PD while increasing 
the sparing of the OARs. 
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Purpose or Objective   
The AAPM TG176 shows examples of dramatic unexpected 
skin effects. This work is aimed to: 
1. Measure maximum doses delivered to skin by 
current SBRT and IMRT treatments and compare 
them to doses calculated by the TPS at the 
same points, and to the calculated maximum 
dose for the skin structure (5 mm thickness 
inwards from body surface). 
2. Compare measured 3DCRT vs IMRT skin doses in 
breast irradiation as well as breast IMRT to 
head-and-neck (H&N) IMRT. 
3. Determine whether current SBRT and IMRT 
treatments could trigger toxicities such as 
those reported in literature. 
Material and Methods  
- We selected 78 patients undergoing radiation therapy. 
The distribution of patients and the most frequent dose 
prescriptions were: 17 3DCRT breast [25x2Gy], 20 IMRT 
breast [27X1.88@breast, 27x2.31Gy@boost], 21 IMRT H&N 
[33x2.12Gy@high-risk; 33x1.8Gy@medim-risk; 
33x1.6Gy@low-risk], 16 lung SBRT [5x11Gy], 4 liver SBRT 
[3x20Gy]. 
- Skin doses were measured with EBT3 radiochromic films 
+ FilmQAPro Software + EPSON EXPRESSION 10000XL 
scanner. 2 cm2 square pieces were mounted in line inside 
sleeves of low-density polyethylene of 50 µm thickness 
that had been cut into strips of 40-80 cm length. Strips 
were fixed onto the patient skin along a section 
perpendicular to the gantry axis including the area of 
maximum calculated dose by the TPS.  
- Readout of film pieces (average of a 1×1 cm2 ROI) was 
repeated thrice with random position to account for 
scanner and film non-uniformities. 
- Calculations were done in Eclipse13.5 with maximum 
resolution (1 mm). We recorded 1) Calculated dose 
@1mm depth at the point corresponding to the maximum 
measured dose, and, 2) Maximum calculated dose for the 
skin structure  
Results  
- Fig1a-e: Measured and calculated doses were different 
but differences were not significant. Calculated doses to 
the skin structure were systematically higher than 
